To investigate potential synergism between existing chemotherapeutics and novel non-psychoactive phytocannabinoids in a bid to create novel combination therapies for cancer that have fewer side-effects.
Get notified when we’re launching.
Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.